Bausch & Lomb Corp

Company Profile

• Business description

  Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

• Contact

  520 Applewood Crescent
  VaughanONL4K 4B4
  CAN

  T: +1 905 695-7700

  https://www.bausch.com

• Sector

  Healthcare

  Stock type

  Defensive

• Industry

  Medical Instruments & Supplies

  Fiscal Year End

  31 December 2025

  Employees

  13,500